GO
| HSI1 | 23,760.77 | -247.78 | 96.62B |
| HSCEI1 | 7,983.93 | -72.83 | 32.05B |
| Back Zoom + Zoom - Block Traded | |
|
Li Ka-shing Provides 30 Histotripsy Kidney Cancer Clinical Trial Slots; HK Becomes First City in Asia to Launch Program
2026-11-11 12:00:16 Li Ka-shing provides CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital with a trial quota for a total of 30 patients, making Hong Kong the first city in Asia to validate the safety and efficacy of treating renal diseases with Histotripsy. Gleneagles Hospital Hong Kong and CUHK Medical Centre are undertaking clinical trials of Histotripsy for pancreatic cancer. Since the trial began in March this year, Gleneagles has completed 20 pancreatic procedures successfully complemented by 6 cases at CUHK Medical Centre which started the trial in June. Including Hong Kong, more than 100 pancreatic cancer cases have been treated worldwide through clinical trials and off-label procedures. ~ AASTOCKS Financial News Website: www.aastocks.com | |